Home / Health / GLP-1 Drugs Cut Sick Leave, Boost Worker Productivity
GLP-1 Drugs Cut Sick Leave, Boost Worker Productivity
21 Jul
Summary
- GLP-1 drug users took 17% less long-term sick leave.
- Medications may save individuals up to 1.5% of their salary.
- Reduced sick leave could increase company productivity.
GLP-1 medications, including Ozempic and Wegovy, are showing economic benefits by reducing employee sick leave. A study found that patients utilizing these drugs took 17% less long-term sick leave.
This reduction in absences translates to potential savings of up to 1.5% of an individual's salary, approximately $866 on average. These medications are prescribed for diabetes or obesity and improve overall health, including cardiovascular events.
While Denmark's generous sick leave policies mean government savings, the study's author suggests similar benefits could apply to the U.S. labor market. Reduced "presenteeism" could boost company productivity and employee earning potential.
